Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on October 25, 2007

Stroke. 2007
Published online before print October 25, 2007, doi: 10.1161/STROKEAHA.107.492660
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/12/3245    most recent
STROKEAHA.107.492660v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitehead, S. N.
Right arrow Articles by Cechetto, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitehead, S. N.
Right arrow Articles by Cechetto, D. F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Alzheimer's Disease
*Neurologic Diseases
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Behavioral Changes and Stroke

Submitted on May 1, 2007
Revised on May 24, 2007
Accepted on May 29, 2007

Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid

Shawn N. Whitehead PhD; Guanliang Cheng MD; Vladimir C. Hachinski MD; and David F. Cechetto PhD*

From the Faculty of Medicine and Dentistry, Department of Anatomy and Cell Biology (S.N.W., G.C., D.F.C.), University of Western Ontario, London, Canada; and the Department of Clinical Neurology (V.C.H.), London Health Sciences Research Centre, University of Western Ontario, London, Canada.

* To whom correspondence should be addressed. E-mail: cechetto{at}uwo.ca.

Background and Purpose—In the elderly, cerebral ischemia (CI) occurs in the presence of high levels of amyloid. Neuroinflammation plays a critical role in the pathophysiology of Alzheimer's disease and CI. This study examined infarct size, neuroinflammation, and cognitive deficits over time in rat models of Alzheimer's disease and CI.

Methods{beta}-amyloid toxicity was modeled using bilateral intracerebroventricular injections of {beta}-amyloid 25 to 35 peptides. CI was modeled using unilateral injections of the potent vasoconstrictor, endothelin-1, into the striatum.

Results—Infarct volumes were higher in the presence of amyloid and compared with the CI model alone. In the CI model alone, the infarct volume was significantly smaller 28 days after surgery compared with 7 days after surgery. However, when Alzheimer's disease and CI models were combined, the infarct volume was significantly larger 28 days after surgery compared with 7 days after surgery. The neuroinflammation in the region of the infarct was also significantly increased. The Barnes circular platform test showed time-dependent increases in memory and learning deficits in the {beta}-amyloid-treated rats that were even greater when {beta}-amyloid treatment was combined with CI.

Conclusions—CI in the presence of high levels of amyloid results in progressive increases in infarct size, neuroinflammation, and cognitive deficits.


Key words: A{beta} peptide • Alzheimer's disease • memory • neuroinflammation • rat • stroke